Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
10/21/1998 | EP0872550A2 cDNA clone HACCH94 that encodes a human 7-transmembrane receptor |
10/21/1998 | EP0872245A1 Methods for treating vascular disorders with activated Protein C |
10/21/1998 | EP0872243A1 Herb composition, herbal paste and herbal plaster made from the same |
10/21/1998 | EP0871756A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations |
10/21/1998 | EP0871721A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells |
10/21/1998 | EP0871710A1 Recombinant c-proteinase and processes, methods and uses thereof |
10/21/1998 | EP0871672A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
10/21/1998 | EP0871667A1 G-protein coupled receptor |
10/21/1998 | EP0871665A1 Insulin derivatives |
10/21/1998 | EP0871661A1 Novel protein domain which binds tyrosine phosphorylated proteins |
10/21/1998 | EP0871647A1 Oligomers which inhibit expression of collagen genes |
10/21/1998 | EP0871644A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
10/21/1998 | EP0871623A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
10/21/1998 | EP0871611A1 New derivatives of glycylanilides, preparation and therapeutical application |
10/21/1998 | EP0871512A1 Localized intravascular delivery of growth factors for promotion of angiogenesis |
10/21/1998 | EP0871496A1 Arteriovenous and venous graft treatments: methods and compositions |
10/21/1998 | EP0871444A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
10/21/1998 | EP0871443A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
10/21/1998 | EP0871420A1 Triacetin as a transdermal penetration enhancer |
10/21/1998 | EP0871376A1 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity |
10/21/1998 | EP0788795A4 Pharmacologically active 2-mercaptobenzimidazole derivatives |
10/21/1998 | EP0775129B1 3-benzoyl benzofuran derivatives as thyroid hormone antagonists |
10/21/1998 | EP0710227B1 Vitamin d analogues |
10/21/1998 | CN1196731A Diglycosylated 1,2-diols as mimetics of sialyl-lewis X and sialyl-Lewis A analogies |
10/21/1998 | CN1196726A 4,5-diaryl oxazole derivatives |
10/21/1998 | CN1196720A Novel vitamin D analogues |
10/21/1998 | CN1196680A Endothelin receptor antagonists |
10/21/1998 | CN1196678A Di-and trivalent small molecule selecting protein inhibitors |
10/21/1998 | CN1196255A Nourishing heart and rising heart rhythm drink and preparation method |
10/21/1998 | CN1196245A Application of stilbene compound and its derivative in preparation of endothelium element antagonist agent |
10/21/1998 | CN1040323C Thiazolidine derivative |
10/20/1998 | US5824784 Genetic engineering with polypeptides and proteins |
10/20/1998 | US5824771 Cyclic corticotropin-releasing factor peptides |
10/20/1998 | US5824691 Guanidine derivatives as inhibitors of Na+ /H+ exchange in cells |
10/20/1998 | US5824682 Vasoconstrictive dihydrobenzopyran derivatives |
10/20/1998 | US5824673 Pharmaceutical compositions comprising metal complexes |
10/20/1998 | US5824655 Anti-transforming growth factor-β gene therapy |
10/20/1998 | US5824550 Voltage-gated calcium channel and antisense oligonucleotides thereto |
10/20/1998 | US5824504 Polynucleotides |
10/20/1998 | US5824305 Bromelain protease of amino acid sequences as bactericides,anticarcinogenic agents, antiinflammatory agents or atherosclerosis |
10/20/1998 | US5824299 Administering an ip-10 polypeptide to decrease non-neoplastic endothelial cell proliferation; treating hemangioma, keloids, proliferative retinal disorder, inflammation, fibrosis |
10/20/1998 | CA1340096C Analogs of atrial natriuretic peptides |
10/15/1998 | WO1998045477A2 Methods for assessing cardiovascular status and compositions for use thereof |
10/15/1998 | WO1998045441A1 Human gtp binding protein |
10/15/1998 | WO1998045434A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |
10/15/1998 | WO1998045427A2 Insulin-like growth factor agonist peptides |
10/15/1998 | WO1998045335A1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation |
10/15/1998 | WO1998045316A1 Novel 4- halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same |
10/15/1998 | WO1998045315A1 Estra-5(10),7-dienes with estrogenic activity |
10/15/1998 | WO1998045309A1 Novel phosphate compounds and their use as medicaments |
10/15/1998 | WO1998045297A1 1,2,3,4-TETRAHYDRO-BENZOFURO[3,2-c]PYRIDINE DERIVATIVES__ |
10/15/1998 | WO1998045292A1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties |
10/15/1998 | WO1998045291A1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties |
10/15/1998 | WO1998045285A1 Somatostatin agonists |
10/15/1998 | WO1998045256A1 Hydroxamic acid derivatives |
10/15/1998 | WO1998045230A1 Chromatographic enantiomer separation of lactones |
10/15/1998 | WO1998044953A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
10/15/1998 | WO1998044938A1 Modified proteins which bind extracellular matrix components |
10/15/1998 | WO1998044922A1 Somatostatin agonists |
10/15/1998 | WO1998044921A1 Somatostatin agonists |
10/15/1998 | WO1998044893A2 Method and formulation for treating vascular disease |
10/15/1998 | WO1998022500A3 Modulation of interactions between myosin and integrins |
10/15/1998 | DE19714343A1 Chromatographische Enantiomerentrennung von Lactonen Chromatographic separation of the enantiomers of lactones |
10/15/1998 | CA2287293A1 Somatostatin agonists |
10/15/1998 | CA2286457A1 Estra-5(10),7-dienes with estrogenic activity |
10/15/1998 | CA2286283A1 Human gtp binding protein |
10/15/1998 | CA2286264A1 Insulin-like growth factor agonist peptides |
10/15/1998 | CA2285906A1 Hydroxamic acid derivatives |
10/15/1998 | CA2285679A1 Novel 4- halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same |
10/15/1998 | CA2285671A1 Methods for assessing cardiovascular status and compositions for use thereof |
10/15/1998 | CA2285604A1 Somatostatin agonists |
10/15/1998 | CA2285223A1 Somatostatin agonists |
10/15/1998 | CA2285020A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |
10/15/1998 | CA2284922A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
10/15/1998 | CA2232861A1 Cdna clone hacch94 that encodes a novel human 7-transmembrane receptor |
10/14/1998 | EP0870825A1 Human protein kinases hYAK3 |
10/14/1998 | EP0870764A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
10/14/1998 | EP0870033A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
10/14/1998 | EP0870024A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
10/14/1998 | EP0869968A1 Growth-hormone secretagogues |
10/14/1998 | EP0869966A1 Prodrugs of thrombin inhibitors |
10/14/1998 | EP0869955A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
10/14/1998 | EP0869952A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof |
10/14/1998 | EP0869945A1 Catechol diethers derivatives useful as pharmaceutical agents |
10/14/1998 | EP0869943A1 Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
10/14/1998 | EP0869942A1 4-((heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
10/14/1998 | EP0869813A1 Method of using beta-interferons to treat restenosis |
10/14/1998 | EP0869810A1 Cyclosporin-containing soft capsule preparations |
10/14/1998 | EP0869808A1 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
10/14/1998 | EP0869782A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
10/14/1998 | EP0678090B1 Piperazine derivatives |
10/14/1998 | EP0656881B1 Ester and combinations of an organic nitrate and a salicylate |
10/14/1998 | EP0577847B1 Morphinan derivative and medicinal use |
10/14/1998 | EP0543861B1 Imidazopyridine derivatives, process for their preparation and their application |
10/14/1998 | CN1196061A Insulin derivatives |
10/14/1998 | CN1196051A Pyrimidine derivatives |
10/14/1998 | CN1195989A Use of thienotriazolodiazepine to increase apolipoprotein A-I levels |
10/14/1998 | CN1195662A New benzenesulfonylamine compounds, process for preparating them and pharmaceutical compositions containing them |
10/14/1998 | CN1195556A Method for preparing medicinal liquor with heart and brain recovery function |
10/14/1998 | CN1195546A Medicine for curing angiocardiopathy and cerebrovascular disease |